ETS transcription factor ETV2 directly converts human fibroblasts into functional endothelial cells

Proceedings of the National Academy of Sciences of the United States of America

Volumn 112, Issue 1, 2015, Pages 160-165

  Morita, Rimpei ^a,b   Suzuki, Mayu ^a,b   Kasahara, Hidenori ^a,b   Shimizu, Nana ^a,b   Shichita, Takashi ^a,b   Sekiya, Takashi ^a,b   Kimura, Akihiro ^a,b   Sasaki, Ken Ichiro ^c   Yasukawa, Hideo ^c   Yoshimura, Akihiko ^a,b  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^c KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Angiogenesis; Direct conversion; Endothelial cells; ETV2

Indexed keywords

ACETYL LOW DENSITY LIPOPROTEIN; ALPHA SMOOTH MUSCLE ACTIN; CD31 ANTIGEN; CHEMOKINE RECEPTOR CXCR4; DOXYCYCLINE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ETS VARIANT 2 TRANSCRIPTION FACTOR; FLI1 TRANSCRIPTION FACTOR; NEUROPILIN 1; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR ERG; TRANSCRIPTION FACTOR FOXC1; TRANSCRIPTION FACTOR FOXC2; TRANSCRIPTION FACTOR GATA 2; TRANSCRIPTION FACTOR TAL1; UNCLASSIFIED DRUG; VASCULAR ENDOTHELIAL CADHERIN; VASCULOTROPIN RECEPTOR 2; VON WILLEBRAND FACTOR; ETV2 PROTEIN, HUMAN; FORKHEAD TRANSCRIPTION FACTOR;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD FLOW; CELL SELECTION; CONTROLLED STUDY; DOWN REGULATION; EMBRYO; ENDOTHELIUM CELL; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LIMB ISCHEMIA; MOUSE; NONHUMAN; PHENOTYPE; PROTEIN EXPRESSION; PROTEIN TRANSPORT; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN FIBROBLAST; UPREGULATION; WESTERN BLOTTING; ANIMAL; BLOOD VESSEL; CELL PROLIFERATION; CYTOLOGY; FIBROBLAST; METABOLISM; NONOBESE DIABETIC MOUSE; PERFUSION; SCID MOUSE;

MUS;

ADULT; ANIMALS; BLOOD VESSELS; CELL PROLIFERATION; ENDOTHELIAL CELLS; FIBROBLASTS; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; MICE, INBRED NOD; MICE, SCID; PERFUSION; TRANSCRIPTION FACTORS;

EID: 84920432079     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1413234112     Document Type: Article

References (34)

1. Kurian L, et al. (2013) Conversion of human fibroblasts to angioblast-like progenitor cells. Nat Methods 10(1):77-83.
2. Lu SJ, et al. (2007) Generation of functional hemangioblasts from human embryonic stem cells. Nat Methods 4(6):501-509.
3. Takebe T, et al. (2013) Vascularized and functional human liver from an iPSC-derived organ bud transplant. Nature 499(7459):481-484.
4. Sancho-Martinez I, Baek SH, Izpisua Belmonte JC (2012) Lineage conversion methodologies meet the reprogramming toolbox. Nat Cell Biol 14(9):892-899.
5. Vierbuchen T, Wernig M (2011) Direct lineage conversions: Unnatural but useful? Nat Biotechnol 29(10):892-907.
6. Margariti A, et al. (2012) Direct reprogramming of fibroblasts into endothelial cells capable of angiogenesis and reendothelialization in tissue-engineered vessels. Proc Natl Acad Sci USA 109(34):13793-13798.
7. Li J, et al. (2013) Conversion of human fibroblasts to functional endothelial cells by defined factors. Arterioscler Thromb Vasc Biol 33(6):1366-1375.
8. Ginsberg M, et al. (2012) Efficient direct reprogramming of mature amniotic cells into endothelial cells by ETS factors and TGFinnodatabeta suppression. Cell 151(3):559-575.
9. Ieda M, et al. (2010) Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors. Cell 142(3):375-386.
10. Vierbuchen T, et al. (2010) Direct conversion of fibroblasts to functional neurons by defined factors. Nature 463(7284):1035-1041.
11. Vierbuchen T, Wernig M (2012) Molecular roadblocks for cellular reprogramming. Mol Cell 47(6):827-838.
12. Hirschi KK (2012) Hemogenic endothelium during development and beyond. Blood 119(21):4823-4827.
13. De Val S, Black BL (2009) Transcriptional control of endothelial cell development. Dev Cell 16(2):180-195.
14. Meadows SM, Salanga MC, Krieg PA (2009) Kruppel-like factor 2 cooperates with the ETS family protein ERG to activate Flk1 expression during vascular development. Development 136(7):1115-1125.
15. Liu F, Walmsley M, Rodaway A, Patient R (2008) Fli1 acts at the top of the transcriptional network driving blood and endothelial development. Curr Biol 18(16):1234-1240.
16. Lee D, et al. (2008) ER71 acts downstream of BMP, Notch, and Wnt signaling in blood and vessel progenitor specification. Cell Stem Cell 2(5):497-507.
17. Costa G, Kouskoff V, Lacaud G (2012) Origin of blood cells and HSC production in the embryo. Trends Immunol 33(5):215-223.
18. Atkins GB, Jain MK, Hamik A (2011) Endothelial differentiation: Molecular mechanisms of specification and heterogeneity. Arterioscler Thromb Vasc Biol 31(7):1476-1484.
19. Dejana E (2010) The role of wnt signaling in physiological and pathological angiogenesis. Circ Res 107(8):943-952.
20. Marcelo KL, Goldie LC, Hirschi KK (2013) Regulation of endothelial cell differentiation and specification. Circ Res 112(9):1272-1287.
21. De Haro L, Janknecht R (2002) Functional analysis of the transcription factor ER71 and its activation of the matrix metalloproteinase-1 promoter. Nucleic Acids Res 30(13):2972-2979.
22. De Val S, et al. (2008) Combinatorial regulation of endothelial gene expression by ets and forkhead transcription factors. Cell 135(6):1053-1064.
23. Vodyanik MA, Thomson JA, Slukvin II (2006) Leukosialin (CD43) defines hematopoietic progenitors in human embryonic stem cell differentiation cultures. Blood 108(6):2095-2105.
24. Skovseth DK, Yamanaka T, Brandtzaeg P, Butcher EC, Haraldsen G (2002) Vascular morphogenesis and differentiation after adoptive transfer of human endothelial cells to immunodeficient mice. Am J Pathol 160(5):1629-1637.
25. Augustin HG, Koh GY, Thurston G, Alitalo K (2009) Control of vascular morphogenesis and homeostasis through the angiopoietin-Tie system. Nat RevMol Cell Biol 10(3):165-177.
26. Sasaki K, et al. (2006) Ex vivo pretreatment of bone marrow mononuclear cells with endothelial NO synthase enhancer AVE9488 enhances their functional activity for cell therapy. Proc Natl Acad Sci USA 103(39):14537-14541.
27. Rackwitz L, et al. (2012) Stem cell- and growth factor-based regenerative therapies for avascular necrosis of the femoral head. Stem Cell Res Therapy 3(1):7.
28. Urbich C, et al. (2005) Cathepsin L is required for endothelial progenitor cell-induced neovascularization. Nat Med 11(2):206-213.
29. van Hinsbergh VW, Engelse MA, Quax PH (2006) Pericellular proteases in angiogenesis and vasculogenesis. Arterioscler Thromb Vasc Biol 26(4):716-728.
30. Veldman MB, et al. (2013) Transdifferentiation of fast skeletal muscle into functional endothelium in vivo by transcription factor Etv2. PLoS Biol 11(6):e1001590.
31. Lammerts van Bueren K, Black BL (2012) Regulation of endothelial and hematopoietic development by the ETS transcription factor Etv2. Curr Opin Hematol 19(3):199-205.
32. Knebel J, De Haro L, Janknecht R (2006) Repression of transcription by TSGA/Jmjd1a, a novel interaction partner of the ETS protein ER71. J Cell Biochem 99(1):319-329.
33. Searles CD (2006) Transcriptional and posttranscriptional regulation of endothelial nitric oxide synthase expression. Am J Physiol Cell Physiol 291(5):C803-C816.
34. Armulik A, Genové G, Betsholtz C (2011) Pericytes: Developmental, physiological, and pathological perspectives, problems, and promises. Dev Cell 21(2):193-215.